Riskpilot← Back to searchSign inGet full accessPedersen`s Laboratorium ApS
APSActiveCVR 36924098Jens Grøns Vej 17Manufacture of other food products n.e.c. · NACE 1089Est. 201511 employeeswww.pedlab.dk
Revenue 2024
DKK 4,4M
-14% vs 2023
EBITDA margin
43.6%
-27% vs 2023
Equity ratio
59.2%
Financial strength
Net profit 2024
DKK 606K
-55% vs 2023
| Revenue | DKK 4,4M | -14% |
| EBITDA | DKK 1,9M | -27% |
| Net profit | DKK 606K | -55% |
| Total assets | DKK 28,3M | +32% |
| Equity | DKK 16,7M | +4% |
| Employees | 11 | — |
Legal name
Pedersen`s Laboratorium ApS
CVR number
36924098
Legal form
Anpartsselskab
NACE code
1089 · Manufacture of other food products n.e.c.
Founded
15. juni 2015
Share capital
DKK 100.000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive biotekvirksomhed med bl.a. produktion af medicinalvarer og anden dermed beslægtet virksomhed
Address
Jens Grøns Vej 17
Phone
+4575859390
Email
info@pedlab.dk
Website
www.pedlab.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4.141 | 3.920 | 5.560 | 5.095 | 4.381 |
| Staff expenses | -2.156 | -2.278 | -3.094 | -2.432 | -2.424 |
| EBITDA | 1.942 | 1.593 | 2.404 | 2.610 | 1.909 |
| Depreciation & amort. | -468 | -543 | -676 | -790 | -802 |
| EBIT | 1.475 | 1.050 | 1.728 | 1.820 | 1.107 |
| Net financials | -65 | -94 | -123 | -107 | -347 |
| Profit before tax | 1.410 | 956 | 1.605 | 1.714 | 760 |
| Tax | 311 | 170 | 270 | 357 | 154 |
| Net profit | 1.099 | 786 | 1.335 | 1.357 | 606 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 17.403 | 17.689 | 20.321 | 21.447 | 28.261 |
| Equity | 12.650 | 13.436 | 14.772 | 16.128 | 16.734 |
| Long-term debt | 157 | 14 | 14 | 0 | 5.894 |
| Short-term debt | 3.455 | 2.928 | 3.955 | 3.562 | 3.722 |
| Total debt | 3.612 | 2.942 | 3.969 | 3.562 | 9.616 |
EBITDA margin
43.6%
This company
15.8%
Market median
+176% vs market
20202024
Equity ratio
59.2%
This company
38.2%
Market median
+55% vs market
20202024
Return on equity
3.6%
This company
18.4%
Market median
-80% vs market
20202024
Net profit margin
13.8%
This company
8.1%
Market median
+70% vs market
20202024
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20202024
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LP Founder | Founder | 2015 |
TR Chief Executive Officer | Chief Executive Officer | 2015 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Pedersen Industries ApS
Pedersen`s Laboratorium ApS Board members of Pedersen`s Laboratorium ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lilli Pedersen | Founder | 0 companies |
| Torben Richard Pedersen | Chief Executive Officer | 0 companies |